Silver Oak Securities, Inc Sab Biotherapeutics, Inc. Transaction History

Silver Oak Securities, Inc

  • $899 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024
BUY
$0.62 - $1.0 $32,172 - $51,891
51,891 New
51,891 $35,000
Q1 2023

May 05, 2023
SELL
$0.42 - $0.75 $21 - $37
-50 Reduced 0.1%
51,891 $23,000
Q4 2022

Feb 02, 2023
BUY
$0.54 - $9.8 $28,048 - $509,021
51,941 New
51,941 $31,000
Q2 2022

Aug 15, 2022
BUY
$1.11 - $3.46 $57,654 - $179,715
51,941 New
51,941 $64,000

Others Institutions Holding SABS

# of Institutions
3
Shares Held
529K
Call Options Held
0
Put Options Held
0
View Full List

About SAB Biotherapeutics, Inc.

SABS Quotes by TradingView
  • Ticker SABS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,030,900
  • Market Cap $133M
  • Description
  • SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...
More about SABS
Track This Portfolio

Track Silver Oak Securities, Inc Portfolio

Follow Silver Oak Securities, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silver Oak Securities, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Silver Oak Securities, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email